Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Clinical Pharmacology and Therapeutics
|
April 16, 2019
Novel Multiple Sclerosis Drugs in the Pipeline
Floriana De Angelis, Jeremy Chataway
CNS Drugs
|
November 24, 2024
Measuring Disease Progression in Multiple Sclerosis Clinical Drug Trials and Impact on Future Patient Care
Floriana De Angelis, Riccardo Nistri, Sarah Wright
CNS Drugs
|
July 4, 2018
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview
Floriana De Angelis, Domenico Plantone, Jeremy Chataway
CNS Drugs
|
May 12, 2016
Secondary Progressive Multiple Sclerosis: Definition and Measurement
Domenico Plantone, Floriana De Angelis, Anisha Doshi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 3, 2010
Neurological picture. Secondary parkinsonism due to arachnoid cyst of the frontal lobe
Dorina Tiple, Floriana De Angelis, Aldo Spallone, et al.
BMJ (Clinical Research Ed.)
|
November 29, 2018
Disease-modifying therapies for multiple sclerosis
Floriana De Angelis, Nevin A John, Wallace J Brownlee
Therapeutic Advances in Neurological Disorders
|
July 2, 2016
Dimethyl fumarate may still have a role in progressive multiple sclerosis
Domenico Plantone, Floriana De Angelis, Anisha Doshi, et al.
Practical Neurology
|
September 24, 2018
New MS diagnostic criteria in practice
Floriana De Angelis, Wallace J Brownlee, Declan T Chard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 3, 2014
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis
Luca Prosperini, Floriana De Angelis, Rosanna De Angelis, et al.
BMC Neurology
|
August 16, 2014
Reversible Pisa syndrome associated to subdural haematoma: case-report
Pasquale Marchione, Aldo Spallone, Marcella Valente, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Clinical Pharmacology and Therapeutics
|
April 16, 2019
Novel Multiple Sclerosis Drugs in the Pipeline
Floriana De Angelis, Jeremy Chataway
CNS Drugs
|
November 24, 2024
Measuring Disease Progression in Multiple Sclerosis Clinical Drug Trials and Impact on Future Patient Care
Floriana De Angelis, Riccardo Nistri, Sarah Wright
CNS Drugs
|
July 4, 2018
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview
Floriana De Angelis, Domenico Plantone, Jeremy Chataway
CNS Drugs
|
May 12, 2016
Secondary Progressive Multiple Sclerosis: Definition and Measurement
Domenico Plantone, Floriana De Angelis, Anisha Doshi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 3, 2010
Neurological picture. Secondary parkinsonism due to arachnoid cyst of the frontal lobe
Dorina Tiple, Floriana De Angelis, Aldo Spallone, et al.
BMJ (Clinical Research Ed.)
|
November 29, 2018
Disease-modifying therapies for multiple sclerosis
Floriana De Angelis, Nevin A John, Wallace J Brownlee
Therapeutic Advances in Neurological Disorders
|
July 2, 2016
Dimethyl fumarate may still have a role in progressive multiple sclerosis
Domenico Plantone, Floriana De Angelis, Anisha Doshi, et al.
Practical Neurology
|
September 24, 2018
New MS diagnostic criteria in practice
Floriana De Angelis, Wallace J Brownlee, Declan T Chard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 3, 2014
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis
Luca Prosperini, Floriana De Angelis, Rosanna De Angelis, et al.
BMC Neurology
|
August 16, 2014
Reversible Pisa syndrome associated to subdural haematoma: case-report
Pasquale Marchione, Aldo Spallone, Marcella Valente, et al.
Page
of 5